Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets seven medicines through its orphan, primary care and specialty business units. Horizon's global headquarters are in Dublin, Ireland.
The Company also has offices in Deerfield, Illinois; Roswell, Georgia; Reinach, Switzerland and Mannheim, Germany.
Executive Vice President, Corporate Strategy and Investor Relations
U.S. Media Contact:
Group Vice President, Corporate Communications
+1 888 506-2562
Ireland Media Contact
+353 (87) 2417373
For important information about the proposed Depomed acquisition click here.